Framework Agreement for the Purchase of Beyfortus® (nirsevimab)

This framework agreement aims to supply the hospital pharmacies of Amgros' stakeholders with the medicinal product Beyfortus® (nirsevimab). The Central Denmark Region's hospital pharmacy will also conduct procurements for resale to Greenland and the Faroe Islands. Beyfortus® is a monoclonal antibody designed for the passive immunization of infants against respiratory syncytial virus (RSV) lower respiratory tract disease. The agreement will facilitate the procurement and distribution of this critical medication, ensuring its availability to healthcare providers within the specified regions. Key aspects of the framework agreement likely include specifications regarding product quality, delivery timelines, storage conditions, and pricing. The scope of the agreement covers the supply chain management of Beyfortus®, from procurement by Amgros to distribution to the participating hospital pharmacies. The inclusion of Greenland and the Faroe Islands highlights the broad geographical reach of this procurement initiative. This tender is crucial for public health, particularly in protecting vulnerable infant populations from severe RSV infections. The agreement underscores Amgros' role in centralizing pharmaceutical procurement to achieve economies of scale and ensure consistent access to essential medicines across its member regions and associated territories.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals, Pharmaceuticals and Vaccines. Located in Denmark, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.